{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/elevate-your-neuromuscular-clinical-studies-fortreas-specialized-expertise-and#webpage",
"url": "https://www.fortrea.com/insights/elevate-your-neuromuscular-clinical-studies-fortreas-specialized-expertise-and",
"name": "Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support",
"description": "Explore how AI in clinical development is transforming clinical trial productivity by improving execution, data integration, and decision-making across the trial lifecycle. Learn how AI clinical trial design and AI clinical trial data management enable more efficient planning, streamlined workflows, and better use of clinical data. Explore how AI clinical trial execution supports faster processes, reduces manual burden, and enhances investigator productivity in complex studies. Learn how AI data integration in clinical trials connects fragmented systems to deliver more accurate, real-time insights for operational and strategic decisions. By embedding AI into clinical trial workflows, organizations can improve efficiency, optimize performance, and drive more productive clinical development outcomes."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support",
"item": "https://www.fortrea.com/insights/elevate-your-neuromuscular-clinical-studies-fortreas-specialized-expertise-and"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/elevate-your-neuromuscular-clinical-studies-fortreas-specialized-expertise-and#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/elevate-your-neuromuscular-clinical-studies-fortreas-specialized-expertise-and#webpage"
},
"headline": "Rare Neuromuscular Clinical Trials and Endpoint Assessment Strategies | Fortrea Insights",
"description": "Explore how rare neuromuscular clinical trials require specialized strategies to address complexity, small patient populations, and evolving endpoint requirements. Learn how neuromuscular endpoint assessment plays a critical role in measuring meaningful clinical outcomes across pediatric and adult neuromuscular clinical trials. Explore how site selection in neuromuscular clinical trials and collaborative clinical trial execution improve study feasibility, operational efficiency, and data quality. Learn how operationalizing neuromuscular clinical trials involves aligning clinical, regulatory, and operational expertise to support consistent execution in rare disease settings. By integrating tailored endpoint strategies, site expertise, and collaborative approaches, organizations can advance rare neuromuscular clinical trials with greater precision and effectiveness.",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2024-10/GettyImages-1171809485.webp"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-11-14",
"dateModified": "2024-11-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-11/AR_0008_Rare%20Neuromuscular_0624_HiRes.pdf",
"encodingFormat": "application/pdf"
}
}
]
}